文献速递头颈部肿瘤放疗放疗物理与技术

弥散α粒子放射治疗促进促免疫原性肿瘤微环境并与程序性细胞死亡蛋白1阻断协同作用

Diffusing Alpha-Emitters Radiation Therapy Promotes a Proimmunogenic Tumor Microenvironment and Synergizes With Programmed Cell Death Protein 1 Blockade.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2022-08-27

该研究在鳞状细胞癌荷瘤BALB/C小鼠中比较DaRT或惰性种子联合抗PD-1抗体或IgG对照的效应。DaRT联合aPD-1较任一单药更有效延缓肿瘤发展并诱导CD3和CD8淋巴细胞浸润,联合治疗还减少脾多形核髓源性抑制细胞并增加肿瘤内颗粒酶B释放。基因表达分析显示DaRT上调凋亡、p53信号、G1/S相关阻滞、干扰素信号和髓系相关转录,下调DNA修复、细胞增殖和notch相关转录。

要点

  • DaRT联合aPD-1较任一单药更有效延缓肿瘤发展并诱导CD3和CD8淋巴细胞浸润。
  • 联合治疗较aPD-1或对照更多减少脾多形核髓源性抑制细胞,颗粒酶B释放仅联合治疗增加。
  • DaRT上调凋亡、p53信号、G1/S相关阻滞、干扰素信号和髓系相关转录,下调DNA修复、细胞增殖和notch相关转录。

核心结论

  • DaRT促进「热」肿瘤微环境并改变免疫抑制,从而增强aPD-1阻断诱导的效应T细胞功能和改善疗效。
  • 该研究为在鳞状细胞癌患者中研究DaRT与aPD-1联合提供依据。

研究设计与样本

  • 鳞状细胞癌荷瘤BALB/C小鼠接受DaRT或惰性种子联合抗PD-1(aPD-1)或IgG对照抗体治疗。
  • 种子插入后16天对肿瘤和脾进行免疫表型分析和免疫组化染色,并测试DaRT联合aPD-1的疗效。
  • DaRT或惰性种子插入后7天提取肿瘤mRNA,使用Nanostring PanCancer-IO-360 panel进行基因表达分析,并对肿瘤和脾进行流式细胞术分析。

主要发现

  • DaRT联合aPD-1较任一单药更有效延缓肿瘤发展并诱导CD3和CD8淋巴细胞浸润。
  • 联合治疗较aPD-1治疗或对照更多减少脾多形核髓源性抑制细胞。
  • 颗粒酶B释放仅在联合治疗中增加,并与T淋巴细胞浸润相关。
  • DaRT插入后7天基因表达和基因集富集分析显示,DaRT上调凋亡、p53信号、G1/S相关阻滞、干扰素信号和髓系相关转录,下调DNA修复、细胞增殖和notch相关转录。
  • 流式细胞术显示DaRT增加树突状细胞活化并导致MDSCs分布改变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Diffusing alpha-emitters Radiation Therapy (DaRT) releases alpha-emitting atoms into the tumor microenvironment. The treatment effectively ablates human and mice xenografts and shows 100% response rates in skin or head and neck squamous cell carcinoma patients. DaRT induces specific and systemic antitumor immune activation and synergizes with immune stimulation and modulation in mice. Here, the transcriptional profile activated by DaRT, and its potential to enhance responsiveness to immune checkpoint inhibition by programmed cell death protein 1 (PD-1) blockade were studied. METHODS AND MATERIALS: Squamous cell carcinoma tumor- bearing BALB/C mice were treated with DaRT or inert seeds in combination with anti-PD-1 (aPD-1) or IgG control antibody. Sixteen days after seed insertion, tumors and spleens were subjected to immunophenotyping and immunohistochemical staining. Combination of DaRT and aPD-1 was tested for efficacy. Gene expression analysis was performed on mRNA extracted from tumors 7 days after DaRT or inert insertion using Nanostring PanCancer-IO-360 panel, and tumors and spleens were subjected to flow cytometry analysis. RESULTS: DaRT in combination with aPD-1 delayed tumor development, induced CD3 and CD8 lymphocytes infiltration more efficiently than either monotherapy. The combined treatment reduced splenic polymorphonuclear myeloid derived suppressor cells more than aPD-1 therapy or control. Granzyme B release in the tumor was increased only in the combinational treatment and was correlated with T-lymphocyte infiltration. Gene expression and gene set enrichment analysis of mRNA levels 7 days after DaRT insertion indicated that DaRT upregulated apoptosis, p53 signaling, G1/S-related arrest, interferon signaling and myeloid related transcription, while downregulating DNA repair, cell proliferation, and notch-related transcription. Flow cytometry showed that DaRT increased dendritic cells activation and led to changes in MDSCs distribution. CONCLUSIONS: DaRT promotes a "hot" tumor microenvironment and changes in immune suppression that lead to a potentiation of aPD-1 blockade induced effector T cell function and improved treatment efficacy. This study provides rationale for investigating DaRT and aPD-1 combination in patients with squamous cell carcinoma.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Mare SD, Nishri Y, Shai A, et al. Diffusing Alpha-Emitters Radiation Therapy Promotes a Proimmunogenic Tumor Microenvironment and Synergizes With Programmed Cell Death Protein 1 Blockade. Int J Radiat Oncol Biol Phys. 2022. PMID: 36031029. doi:10.1016/j.ijrobp.2022.08.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。